We are live on ! Find out more
MTEM

Molecular Templates, Inc.
MTEM

Delisted

MTEM was delisted on the 24th of December, 2024.

Back to rankings

36 hedge funds and large institutions have $43.6M invested in Molecular Templates, Inc. in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 4

100% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 5

63% more capital invested

Capital invested by funds: $26.9M → $43.6M (+$16.8M)

24% more funds holding

Funds holding: 29 → 36 (+7)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
36
Holders Change
+7
Holders Change %
+24.14%
% of All Funds
0.82%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
10
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IBT
International Biotechnology Trust
United Kingdom
+$1.67M
2
Millennium Management
Millennium Management
New York
+$603K
3
LSC
Lyon Street Capital
California
+$465K
4
AA
ALPS Advisors
Colorado
+$249K
5
JP Morgan Chase
JP Morgan Chase
New York
+$205K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$219K
2
OAM
Oxford Asset Management
United Kingdom
-$140K
3
Citadel Advisors
Citadel Advisors
Florida
-$81K
4
PAM
Panagora Asset Management
Massachusetts
-$69K
5
Renaissance Technologies
Renaissance Technologies
New York
-$36K
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
1
Caxton Corporation
New Jersey
$10.2M – – –
BI
2
BVF Inc
California
$7.26M – – –
PA
3
Perceptive Advisors
New York
$7.25M – – –
First Eagle Investment Management
4
First Eagle Investment Management
New York
$6.46M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$3.42M -$219K -1,747 -7%
IBT
6
International Biotechnology Trust
United Kingdom
$2.48M +$1.67M +13,297 +414%
BlackRock
7
BlackRock
New York
$1.46M +$2.01K +16 +0.2%
BBA
8
Baker Bros. Advisors
New York
$726K – – –
Millennium Management
9
Millennium Management
New York
$722K +$603K +4,804 New
LSC
10
Lyon Street Capital
California
$557K +$465K +3,708 New
Renaissance Technologies
11
Renaissance Technologies
New York
$454K -$36K -287 -9%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$436K – – –
Fidelity Investments
13
Fidelity Investments
Massachusetts
$359K – – –
JP Morgan Chase
14
JP Morgan Chase
New York
$355K +$205K +1,635 +226%
AA
15
ALPS Advisors
Colorado
$298K +$249K +1,986 New
California Public Employees Retirement System
16
California Public Employees Retirement System
California
$181K – – –
Northern Trust
17
Northern Trust
Illinois
$163K -$126 -1 -0.1%
BCM
18
BlueCrest Capital Management
Jersey
$157K +$131K +1,043 New
ARTA
19
A.R.T. Advisors
New York
$155K +$130K +1,034 New
Two Sigma Investments
20
Two Sigma Investments
New York
$131K +$110K +874 New
PP
21
Paloma Partners
Connecticut
$113K +$94.4K +752 New
Wells Fargo
22
Wells Fargo
California
$101K +$79.5K +633 +1,758%
Morgan Stanley
23
Morgan Stanley
New York
$75K +$21.2K +169 +51%
PAM
24
Panagora Asset Management
Massachusetts
$44K -$69K -550 -65%
AG
25
Advisor Group
Arizona
$30K +$24.5K +195 +3,900%
1
2

MTEM Hedge Fund Activity: Q4 2017 in Review

36 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Molecular Templates, Inc. (MTEM) for Q4 2017, worth a combined $43.6M — up 63% from $26.9M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new MTEM positions and 4 closed out — a net gain of 7 holders — while 10 added to existing stakes and 5 trimmed.

The largest buyer was International Biotechnology Trust, adding an estimated $1.67M. The largest seller was Vanguard Group, cutting an estimated $219K.

  • 36 institutional investors held Molecular Templates, Inc. (MTEM) as of Q4 2017, up from 29 in Q3 2017.
  • Funds reported $43.6M of Molecular Templates, Inc. stock for Q4 2017, up 63% quarter-over-quarter.
  • 11 funds opened new Molecular Templates, Inc. positions in Q4 2017 and 4 closed out, a net change of +7 holders.
  • The largest Molecular Templates, Inc. buyer in Q4 2017 was International Biotechnology Trust, an estimated $1.67M added.
  • The largest Molecular Templates, Inc. seller in Q4 2017 was Vanguard Group, an estimated $219K sold.

Based on aggregated 13F filings for Q4 2017.